Focus: Blacksmith Medicines is a San Diego-based biotechnology company specializing in human metalloenzyme-targeted medicines focused on ophthalmology and neurology indications. The company is publicly traded with a lean operational footprint of 20 active job openings.
Profile data last refreshed 54m ago · AI intelligence enriched 2w ago
Stable — net +3 jobs in 30d
5 added, 2 removed. Backfill posture.
Best suited for career builders comfortable in a commercialization-focused, public-company biotech with a narrow product portfolio and limited near-term pipeline catalysts.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Established NDA-approved mast cell stabilizer facing loss of exclusivity with no specified LOE date; represents a legacy commercial asset rather than growth driver.
Help build intelligence for Blacksmith Medicines
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Blacksmith Medicines's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles